Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Taiho Oncology, Inc.
Roswell Park Cancer Institute
Alterome Therapeutics, Inc.
ToLymph Inc.
Emory University
Nuvectis Pharma, Inc.
George Washington University
Eastern Cooperative Oncology Group
AstraZeneca
Pfizer
Replimune Inc.
AstraZeneca
Tagworks Pharmaceuticals BV
Avenzo Therapeutics, Inc.
Boston Scientific Corporation
Shanghai Pulmonary Hospital, Shanghai, China
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Emory University
Pheon Therapeutics
NRG Oncology
Auricula Biosciences Inc.
DualityBio Inc.
NATCO Pharma Ltd.
Pfizer
Tanabe Pharma America, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Yonsei University
Yonsei University
Iovance Biotherapeutics, Inc.
Mayo Clinic
Cedars-Sinai Medical Center
St. Jude Children's Research Hospital
SillaJen, Inc.
Thomas Jefferson University
Genelux Corporation
Fudan University
CNAO National Center of Oncological Hadrontherapy
Case Comprehensive Cancer Center
Turning Point Therapeutics, Inc.
Marengo Therapeutics, Inc.
University of Pittsburgh
Sun Yat-sen University
University of Alabama at Birmingham